The nuclear medicine program at New Bolton Center, begun in 1993 under the supervision of Dr. Michael Ross, has become one of the busiest programs of its kind in the world.
Nuclear medicine, commonly referred to as nuclear or bone scintigraphy, involves the administration of a radiopharmaceutical that preferentially binds to bone where there is injury or at sites of active bone formation. Used in conjunction with lameness examination and diagnostic analgesia, this modality is hugely important in identifying the cause of lameness.